KORU Medical Systems Inc. (KRMD)
KORU Medical Systems Statistics
Share Statistics
KORU Medical Systems has 45.96M shares outstanding. The number of shares has increased by 0.28% in one year.
Shares Outstanding | 45.96M |
Shares Change (YoY) | 0.28% |
Shares Change (QoQ) | -0.04% |
Owned by Institutions (%) | 37.49% |
Shares Floating | 43.74M |
Failed to Deliver (FTD) Shares | 318 |
FTD / Avg. Volume | 0.16% |
Short Selling Information
The latest short interest is 486.92K, so 1.06% of the outstanding shares have been sold short.
Short Interest | 486.92K |
Short % of Shares Out | 1.06% |
Short % of Float | 1.14% |
Short Ratio (days to cover) | 11.67 |
Valuation Ratios
The PE ratio is -29.07 and the forward PE ratio is -58.4. KORU Medical Systems's PEG ratio is 0.51.
PE Ratio | -29.07 |
Forward PE | -58.4 |
PS Ratio | 5.24 |
Forward PS | 2.3 |
PB Ratio | 10.49 |
P/FCF Ratio | -109.04 |
PEG Ratio | 0.51 |
Enterprise Valuation
KORU Medical Systems Inc. has an Enterprise Value (EV) of 105.14M.
EV / Earnings | -17.33 |
EV / Sales | 3.12 |
EV / EBITDA | -18.92 |
EV / EBIT | -18.92 |
EV / FCF | -65.02 |
Financial Position
The company has a current ratio of 2.66, with a Debt / Equity ratio of 0.22.
Current Ratio | 2.66 |
Quick Ratio | 2.27 |
Debt / Equity | 0.22 |
Total Debt / Capitalization | 18.11 |
Cash Flow / Debt | -0.09 |
Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.36% and return on capital (ROIC) is -27.06%.
Return on Equity (ROE) | -0.36% |
Return on Assets (ROA) | -0.22% |
Return on Capital (ROIC) | -27.06% |
Revenue Per Employee | $420,580.79 |
Profits Per Employee | $-75,832.91 |
Employee Count | 80 |
Asset Turnover | 1.24 |
Inventory Turnover | 4.39 |
Taxes
Income Tax | -2.89K |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 9.75% in the last 52 weeks. The beta is 0.74, so KORU Medical Systems's price volatility has been higher than the market average.
Beta | 0.74 |
52-Week Price Change | 9.75% |
50-Day Moving Average | 3.69 |
200-Day Moving Average | 3.09 |
Relative Strength Index (RSI) | 29.28 |
Average Volume (20 Days) | 198K |
Income Statement
In the last 12 months, KORU Medical Systems had revenue of 33.65M and earned -6.07M in profits. Earnings per share was -0.13.
Revenue | 33.65M |
Gross Profit | 21.33M |
Operating Income | -5.56M |
Net Income | -6.07M |
EBITDA | -5.56M |
EBIT | -5.56M |
Earnings Per Share (EPS) | -0.13 |
Balance Sheet
The company has 9.58M in cash and 3.72M in debt, giving a net cash position of 5.86M.
Cash & Cash Equivalents | 9.58M |
Total Debt | 3.72M |
Net Cash | 5.86M |
Retained Earnings | -29.38M |
Total Assets | 27.22M |
Working Capital | 11.93M |
Cash Flow
In the last 12 months, operating cash flow was -319.72K and capital expenditures -1.3M, giving a free cash flow of -1.62M.
Operating Cash Flow | -319.72K |
Capital Expenditures | -1.3M |
Free Cash Flow | -1.62M |
FCF Per Share | -0.04 |
Margins
Gross margin is 63.4%, with operating and profit margins of -16.52% and -18.03%.
Gross Margin | 63.4% |
Operating Margin | -16.52% |
Pretax Margin | -18.04% |
Profit Margin | -18.03% |
EBITDA Margin | -16.52% |
EBIT Margin | -16.52% |
FCF Margin | -4.81% |
Dividends & Yields
KRMD does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -5.02% |
FCF Yield | -1.36% |
Analyst Forecast
The average price target for KRMD is $4.75, which is 83.4% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $4.75 |
Price Target Difference | 83.4% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Scores
Altman Z-Score | 6.39 |
Piotroski F-Score | 3 |